RFU

Promising New Data Published on Potential Therapy to Boost Effectiveness of Pancreatic Cancer Treatments

Retrieved on: 
Tuesday, March 26, 2024
Toxicity, Cell, Development, Survival, BLR, Disease, American Cancer Society, PNAC, Research, University, Quality of life, Cancer, IND, Pharmacology, Pancreatic cancer, Mario, Potential, RFU, Therapy, Helix, Person, Pharmaceutical industry

The data points to a promising strategy to boost the effectiveness of existing drugs in pancreatic cancer and other solid-tumor cancers.

Key Points: 
  • The data points to a promising strategy to boost the effectiveness of existing drugs in pancreatic cancer and other solid-tumor cancers.
  • According to the American Cancer Society , some 66,000 persons in the U.S. are diagnosed annually with pancreatic cancer, a disease with a very low survival rate that is projected to take 51,000 lives in 2024.
  • "Finding an approach to use lower doses while maintaining efficacy has been a constant search for cancer treatments."
  • "BLR-100 targets the formation of the protective tumor stroma, a fibrotic-like element that is thought to retard the entry of chemo-therapeutic agents."

Leader in Clinical Pharmacogenomics Named Dean of Rosalind Franklin University's College of Pharmacy

Retrieved on: 
Wednesday, January 31, 2024
Public, College, RFU, Research, Florida College, FCCP, Translational research, Teaching, Safety, University of Florida Health, Doctor of Pharmacy, Artificial intelligence, UF, Virginia Commonwealth University, Medicine, Genomics, Learning, Education, Accreditation, Bangladesh Technical Education Board, University, Pharmacist, Nursing

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Kristin Wiisanen, PharmD, FAPhA, FCCP, is the new dean of the College of Pharmacy at Rosalind Franklin University of Medicine and Science.

Key Points: 
  • NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Kristin Wiisanen, PharmD, FAPhA, FCCP, is the new dean of the College of Pharmacy at Rosalind Franklin University of Medicine and Science.
  • Named to the post after a national search, Dr. Wiisanen is a national leader in clinical pharmacogenomics, a field that works to improve the safety and efficacy of drugs by incorporating genetic information.
  • "RFU's mission to deliver interprofessional education separates the College of Pharmacy from other programs," she said.
  • Dr. Wiisanen earned her Doctor of Pharmacy degree from UF and completed a community pharmacy practice residency at Virginia Commonwealth University School of Pharmacy.

New Round of Grants for the Rosalind Franklin University, DePaul Research Collaboration Targets Malaria, Smoking and Septic Shock

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Intelligence, Doctor of Philosophy, Septic shock, Immunity, De Paul, RFU, Research, AI, MD, University, Outline of health sciences, CDM, Biomedical Research, Tobacco, DePaul University, Health care, Machine learning, DVM, Artificial intelligence, Inhalation

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Malaria, cigarette smoking and septic shock kill millions of people every year.

Key Points: 
  • NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Malaria, cigarette smoking and septic shock kill millions of people every year.
  • In a fresh round of funding, DePaul University and Rosalind Franklin University of Medicine and Science are supporting faculty research projects that bring together artificial intelligence and biomedical discovery to address these health care challenges.
  • The latest round of grants, totaling a combined $200,510, launched interdisciplinary research teams that include robotics experts, computer engineers, a biophysicist, a psychologist and an immunologist.
  • "Self-Operating System for Circulatory Management of Sepsis, Severe Sepsis, and Septic Shock" — RFU: Raul Gazmuri, MD, PhD, FCCM ; DePaul: Mohammad Umer Huzaifa, PhD; $66,675.

Rosalind Franklin University Awarded $8.1 Million in Illinois Board of Higher Education Capital Funds

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Intelligence, RFU, Research, Society, Diagnosis, IRP, Education, Health, Student, Innovation, Nursing

The university has been awarded $8.1 million in funds provided by the Illinois Board of Higher Education's Independent Colleges Capital Investment Grant Program to bolster existing training infrastructure, including renovation of general clinical skills labs, modernization of the gross anatomy lab and purchase of state-of-the-art simulation equipment.

Key Points: 
  • The university has been awarded $8.1 million in funds provided by the Illinois Board of Higher Education's Independent Colleges Capital Investment Grant Program to bolster existing training infrastructure, including renovation of general clinical skills labs, modernization of the gross anatomy lab and purchase of state-of-the-art simulation equipment.
  • The new funds will also enhance RFU's outreach to community partners who support its academic-to-workforce pathways.
  • An early adopter of healthcare simulation, RFU is an accredited center through the Society for Simulation in Healthcare.
  • The IBHE awarded a total of $400 million in grants through the Independent Colleges Capital Investment Grant program in partnership with the Illinois Capital Development Board.

Endeavor Health Partners With Rosalind Franklin University to Expand Access to Care

Retrieved on: 
Tuesday, January 30, 2024
Diabetes, CCC, Health, Housing, RFU, Food, Health education, APN, COVID-19, Osteoporosis, Workforce, Cholesterol, Cardiovascular disease

NORTH CHICAGO, Ill., Jan. 30, 2024 /PRNewswire/ -- Endeavor Health continues its strong support of Rosalind Franklin University's community health outreach program, which has expanded services through Endeavor's Community Investment Fund (CIF).

Key Points: 
  • NORTH CHICAGO, Ill., Jan. 30, 2024 /PRNewswire/ -- Endeavor Health continues its strong support of Rosalind Franklin University's community health outreach program, which has expanded services through Endeavor's Community Investment Fund (CIF).
  • Endeavor Health's Community Investment Fund has helped Rosalind Franklin University improve access to health care.
  • RFU's Community Care Connection (CCC) has used $1.75 million in CIF funds to improve the health of Lake County communities.
  • RFU is the second-highest award recipient among 47 local organizations across the Chicagoland area collaborating with Endeavor Health under the $21.4 million CIF program, which is focused on behavioral health, violence prevention, housing and food insecurity, access to care and workforce development.

Rosalind Franklin University Announces First Certified Registered Nurse Anesthetist Program Accredited by the State of Colorado

Retrieved on: 
Tuesday, January 16, 2024
Research, Many, Anesthesia, University of Colorado, Faculty, Curriculum, University, RFU, Education, Certified Registered Nurse Anesthetist, Nursing, Population growth, Mercer, Doctor of Philosophy, Organization, Nursing care plan, DNP, Ageing

NORTH CHICAGO, Ill., Jan. 16, 2024 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science will help meet a critical need for certified registered nurse anesthetists (CRNAs) in Colorado through its Doctor of Nursing Practice in Nurse Anesthesia program — the first program accredited by the Colorado Department for Higher Education to offer classroom, simulation and clinical nurse anesthesia training in the state.

Key Points: 
  • NORTH CHICAGO, Ill., Jan. 16, 2024 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science will help meet a critical need for certified registered nurse anesthetists (CRNAs) in Colorado through its Doctor of Nursing Practice in Nurse Anesthesia program — the first program accredited by the Colorado Department for Higher Education to offer classroom, simulation and clinical nurse anesthesia training in the state.
  • Rosalind Franklin University helps meet a critical need for certified registered nurse anesthetists in Colorado.
  • CRNAs are advanced practice nurses who are board certified to administer every type of anesthesia in all healthcare settings.
  • Colorado faces an anticipated shortage of 10,000 registered nurses by 2026, according to a 2021 analysis by the consulting firm Mercer.

Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University Announces Historic $1 Million Matching-Fund Scholarship Challenge

Retrieved on: 
Wednesday, December 13, 2023
Gait, Research, Conditional sentence, Student, Patient, RFU, Master of Science, DPM, Podiatry, Lead, Education, Pharmaceutical industry, Nursing, Scholl

NORTH CHICAGO, Ill., Dec. 13, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science (RFU) announces a historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine .

Key Points: 
  • NORTH CHICAGO, Ill., Dec. 13, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science (RFU) announces a historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine .
  • Historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine.
  • The extraordinary $1 million Scholl Matching Gift Challenge comes from an anonymous Scholl College alum and their spouse, generously committing to match all gifts toward the college dollar-for-dollar.
  • Matching funds will grow an endowed scholarship to provide four-year, need-based scholarships for Scholl College students in perpetuity.

Rosalind Franklin University Innovation and Research Park Welcomes Three Squared Biosciences, Focused on Gut Microbiome Solutions for Chronic Diseases

Retrieved on: 
Tuesday, November 28, 2023
Atherosclerosis, Innovation Place Research Park, Hypertension, NAFLD, Research, Alzheimer's disease, Colorectal cancer, Parkinson's disease, Risk, Disease, Fungal infection, Extrapyramidal system, Intelligence, RFU, Obesity, Non-alcoholic fatty liver disease, Tenant, IBD, MBA, University, Doctor of Philosophy, Innovation, Diabetes, Environment, IRP, Pharmaceutical industry, Management, Science

NORTH CHICAGO, Ill., Nov. 28, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announces a new tenant in its Innovation and Research Park: 32 (Three Squared) Biosciences , which builds companies that leverage artificial intelligence to better understand the gut microbiome and uses that knowledge to prevent diseases.

Key Points: 
  • NORTH CHICAGO, Ill., Nov. 28, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announces a new tenant in its Innovation and Research Park: 32 (Three Squared) Biosciences , which builds companies that leverage artificial intelligence to better understand the gut microbiome and uses that knowledge to prevent diseases.
  • 32 Biosciences and its subsidiary companies, Gateway Biome and Covira , signed an agreement, effective Nov. 1, for space within the Innovation and Research Park .
  • 32 Biosciences was formed to harness the full potential of Gateway Biome and Covira, spinouts from the University of Chicago.
  • "RFU is committed to expanding collaboration between academic research and the life science industry to improve prevention and treatment of disease."

Rosalind Franklin University Announces New Director of Center for Genetic Diseases

Retrieved on: 
Thursday, November 16, 2023
Cell biology, Research, Loyola University Medical Center, Microbiology, Cornell University, Student, Multimedia, DSM-IV codes, RFU, Messenger, Therapy, NIH, University, Doctor of Philosophy, Washington State University, Genetic disorder, RNA, COVID, Science

NORTH CHICAGO, Ill., Nov. 16, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announces the appointment of molecular biologist Weihang "Valerie" Chai, PhD, as director of the Center for Genetic Diseases .

Key Points: 
  • NORTH CHICAGO, Ill., Nov. 16, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announces the appointment of molecular biologist Weihang "Valerie" Chai, PhD, as director of the Center for Genetic Diseases .
  • "She's the ideal person to build the center along new directions — approaching genetic diseases, in part, through a focus on cancer research.
  • Previously, she was a tenured associate professor for the Elson S. Floyd College of Medicine at Washington State University.
  • She earned her doctorate in microbiology from Cornell University and completed a postdoctoral fellowship in cell biology at the University of Texas Southwestern Medical Center at Dallas.

ROSALIND FRANKLIN UNIVERSITY RESEARCHER AWARDED NIH FUNDING TO INVESTIGATE LINKS BETWEEN DOWN SYNDROME AND ALZHEIMER'S DISEASE

Retrieved on: 
Tuesday, July 25, 2023
Neurodegenerative disease, National Institute on Aging, PNAS, Rosalind Franklin University of Medicine and Science, New York University Grossman School of Medicine, Chicago Medical School, NYU, Pathology, Research, Attention, Multimedia, RFU, Doctor of Philosophy, DS, Down syndrome, Intellectual disability, Ageing, Alzheimer's disease, Chromosome, Dementia, Patient, AD, Therapy, Function (mathematics), Memory, Pharmaceutical industry, Medical device, New York University

A professor and director of RFU's Center for Neurodegenerative Disease and Therapeutics , Dr. Stutzmann has long studied the early neuronal pathology that develops in AD.

Key Points: 
  • A professor and director of RFU's Center for Neurodegenerative Disease and Therapeutics , Dr. Stutzmann has long studied the early neuronal pathology that develops in AD.
  • Pathological hallmarks of AD include beta-amyloid and tau pathology, synaptic deficits, and neurodegeneration of key circuits underlying memory, attention and executive function.
  • The extent to which these pathologies are found in DS are a significant component of the collaborative research project.
  • ROSALIND FRANKLIN UNIVERSITY encompasses six colleges and more than 10 research centers and institutes.